Eloquent AI | $7,400,000 | (Sep 12, 2025)
Meela Inc. | $3,500,000 | (Sep 12, 2025)
TrustNXT | $1,874,888 | (Sep 12, 2025)
Certified by Founder
Lodge
Bicara Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/03/2023
- Series B
- $108,000,000
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.
- Industry Biotechnology Research
- Website https://www.bicara.com/
- LinkedIn https://www.linkedin.com/company/bicara-therapeutics/
Kriya Therapeutics, Inc. | $320,000,000 | (Sep 12, 2025)
Goodpath | $18,000,000 | (Sep 12, 2025)
BacAlt | $2,037,362 | (Sep 12, 2025)
Quack AI | $7,000,000 | (Sep 12, 2025)
Diana Health (We're Hiring!) | $55,000,000 | (Sep 12, 2025)
OpenHealth Technologies | $3,000,000 | (Sep 12, 2025)
Brain Co. | $30,000,000 | (Sep 12, 2025)
AegisAI Security | $13,000,000 | (Sep 12, 2025)
Clyx | $14,000,000 | (Sep 12, 2025)